Retinoic Acid Receptor-related Orphan Receptor Alpha As a Therapeutic Target in the Treatment of Dyslipidemia and Atherosclerosis
Overview
Affiliations
Retinoic acid receptor-related orphan receptor alpha (RORalpha) is a member of the nuclear receptor family. Recently, cholesterol (derivatives) has been identified as an RORalpha ligand and deorphanized this receptor. RORalpha is expressed in many tissues and is therefore a regulator of multiple biological processes. Studies of staggerer mice and in vitro assays indicate a beneficial modulatory role of RORalpha in the pathogenesis of dyslipidemia, inflammation and atherosclerosis. This paper provides an overview on the role of RORalpha in lipid metabolism and discusses its potential therapeutic option for treating lipid and inflammatory disorders leading to atherosclerosis.
Novel Therapeutic Potential of Retinoid-Related Orphan Receptor α in Cardiovascular Diseases.
Chen Y, Zhang S, Gong W, Zheng Y, Shen J, Liu X Int J Mol Sci. 2023; 24(4).
PMID: 36834872 PMC: 9959049. DOI: 10.3390/ijms24043462.
Cytochrome P450 1B1: A Key Regulator of Ocular Iron Homeostasis and Oxidative Stress.
Song Y, Annalora A, Marcus C, Jefcoate C, Sorenson C, Sheibani N Cells. 2022; 11(19).
PMID: 36230892 PMC: 9563809. DOI: 10.3390/cells11192930.
ROR: Nuclear Receptor for Melatonin or Not?.
Ma H, Kang J, Fan W, He H, Huang F Molecules. 2021; 26(9).
PMID: 34064466 PMC: 8124216. DOI: 10.3390/molecules26092693.
Potential role of CYP1B1 in the development and treatment of metabolic diseases.
Li F, Zhu W, Gonzalez F Pharmacol Ther. 2017; 178:18-30.
PMID: 28322972 PMC: 5600638. DOI: 10.1016/j.pharmthera.2017.03.007.
The orphan nuclear receptor TR4 is a vitamin A-activated nuclear receptor.
Zhou X, Suino-Powell K, Xu Y, Chan C, Tanabe O, Kruse S J Biol Chem. 2010; 286(4):2877-85.
PMID: 21068381 PMC: 3024783. DOI: 10.1074/jbc.M110.168740.